These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 29704489)
1. Evaluation of the whole body physiologically based pharmacokinetic (WB-PBPK) modeling of drugs. Munir A; Azam S; Fazal S; Bhatti AI J Theor Biol; 2018 Aug; 451():1-9. PubMed ID: 29704489 [TBL] [Abstract][Full Text] [Related]
2. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach. Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937 [TBL] [Abstract][Full Text] [Related]
3. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles. Peters SA Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054 [TBL] [Abstract][Full Text] [Related]
4. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. Poulin P; Theil FP J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112 [TBL] [Abstract][Full Text] [Related]
5. Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation. Ellison CA Regul Toxicol Pharmacol; 2018 Nov; 99():61-77. PubMed ID: 30201539 [TBL] [Abstract][Full Text] [Related]
6. Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Edginton AN; Theil FP; Schmitt W; Willmann S Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1143-52. PubMed ID: 18721109 [TBL] [Abstract][Full Text] [Related]
7. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery. Lüpfert C; Reichel A Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947 [TBL] [Abstract][Full Text] [Related]
8. Successful Prediction of Human Pharmacokinetics by Improving Calculation Processes of Physiologically Based Pharmacokinetic Approach. Mayumi K; Ohnishi S; Hasegawa H J Pharm Sci; 2019 Aug; 108(8):2718-2727. PubMed ID: 30876861 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis. Peters SA Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055 [TBL] [Abstract][Full Text] [Related]
10. Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles. Li M; Zou P; Tyner K; Lee S AAPS J; 2017 Jan; 19(1):26-42. PubMed ID: 27834047 [TBL] [Abstract][Full Text] [Related]
11. Integration of Engineered Delivery with the Pharmacokinetics of Medical Candidates via Physiology-Based Pharmacokinetics. Yang Y; Zhang X Methods Mol Biol; 2022; 2486():57-69. PubMed ID: 35437718 [TBL] [Abstract][Full Text] [Related]
12. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates. Fenneteau F; Poulin P; Nekka F J Pharm Sci; 2010 Jan; 99(1):486-514. PubMed ID: 19479982 [TBL] [Abstract][Full Text] [Related]
13. Early identification of drug-induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration-time profiles in rat. Peters SA; Hultin L J Pharmacokinet Pharmacodyn; 2008 Feb; 35(1):1-30. PubMed ID: 17963025 [TBL] [Abstract][Full Text] [Related]
14. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization. Peters SA; Ungell AL; Dolgos H Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647 [TBL] [Abstract][Full Text] [Related]
15. Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model. Asami S; Kiga D; Konagaya A BMC Syst Biol; 2017 Dec; 11(Suppl 7):129. PubMed ID: 29322928 [TBL] [Abstract][Full Text] [Related]
16. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals. Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180 [TBL] [Abstract][Full Text] [Related]
18. A Combination of Machine Learning and PBPK Modeling Approach for Pharmacokinetics Prediction of Small Molecules in Humans. Li Y; Wang Z; Li Y; Du J; Gao X; Li Y; Lai L Pharm Res; 2024 Jul; 41(7):1369-1379. PubMed ID: 38918309 [TBL] [Abstract][Full Text] [Related]
19. Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling. Li GF; Wang K; Chen R; Zhao HR; Yang J; Zheng QS Acta Pharmacol Sin; 2012 Nov; 33(11):1359-71. PubMed ID: 23085739 [TBL] [Abstract][Full Text] [Related]
20. PBPK modeling and simulation in drug research and development. Zhuang X; Lu C Acta Pharm Sin B; 2016 Sep; 6(5):430-440. PubMed ID: 27909650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]